CAS: 1337531-06-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK2593074A REF: 3D-MDC53106CAS: 1337531-06-2 | Min. 95% | To inquire | Wed 22 Jan 25 | |
GSK2593074A REF: TM-T11484CAS: 1337531-06-2 | 100% | 112.00 €~1,336.00 € | Wed 29 Jan 25 |
GSK2593074A
CAS:1337531-06-2
GSK2593074A is a potent inhibitor of the VSMACs, which are proteins that interact with the …
Formula:
C27H23N5OS
Purity:
Min. 95%
Molecular weight:
465.57 g/mol
Ref: 3D-MDC53106
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
GSK2593074A
CAS:1337531-06-2
GSK2593074A (GSK'074) is a programmed necrosis inhibitor that displays inhibitory effects on RIP1 and RIP3.
Formula:
C27H23N5OS
Purity:
100%
Color and Shape:
Solid
Molecular weight:
465.57
Ref: TM-T11484
1mg | 112.00 € | ||
5mg | 270.00 € | ||
10mg | 425.00 € | ||
25mg | 713.00 € | ||
50mg | 998.00 € | ||
100mg | 1,336.00 € | ||
1mL*10mM (DMSO) | 299.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025